000 01267 a2200313 4500
005 20250512035337.0
264 0 _c19880726
008 198807s 0 0 eng d
022 _a0934-9723
024 7 _a10.1007/BF01962182
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aHobbs, M
245 0 0 _aEvaluation of in vitro antifungal activity of LY121019.
_h[electronic resource]
260 _bEuropean journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology
_cFeb 1988
300 _a77-80 p.
_bdigital
500 _aPublication Type: Comparative Study; Journal Article
650 0 4 _aAmphotericin B
_xpharmacology
650 0 4 _aAntifungal Agents
_xpharmacology
650 0 4 _aCandida
_xdrug effects
650 0 4 _aCandida albicans
_xdrug effects
650 0 4 _aEchinocandins
650 0 4 _aHumans
650 0 4 _aPeptides
_xpharmacology
650 0 4 _aPeptides, Cyclic
700 1 _aPerfect, J
700 1 _aDurack, D
773 0 _tEuropean journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology
_gvol. 7
_gno. 1
_gp. 77-80
856 4 0 _uhttps://doi.org/10.1007/BF01962182
_zAvailable from publisher's website
999 _c3138183
_d3138183